Organization
Abbott GmbH & Co KG, Ludwigshafen, Germany
2 abstracts
Abstract
ADALIMUMAB (HUMIRA®) THERAPY IS EFFECTIVE AND WELL–TOLERATED IN ANKYLOSING SPONDYLITIS (AS), RHEUMATOID ARTHRITIS (RA), OR PSORIATIC ARTHRITIS (PSA) PATIENTS WITH A HISTORY OF ANTI–TNF THERAPYOrg: Charité – University Medicine, Berlin, Germany, University Hospital, Gent, Belgium, Abbott GmbH & Co KG, Ludwigshafen, Germany,
Abstract
ADALIMUMAB (HUMIRA®) THERAPY IMPROVES INFLAMMATORY BOWEL DISEASE (IBD) AND PSORIASIS (PS) IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS)Org: Rheumazentrum Ruhrgebiet, Herne, Germany, Ospedale San Carlo di Potenza, Córdoba, Spain, Sismanoglio Hospital, Athens, Greece, Abbott GmbH & Co KG, Ludwigshafen, Germany, Charité – University Medicine Berlin, Berlin, Germany,